These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 30636544)

  • 1. Continuous Subcutaneous Insulin Infusion Initiation Is Associated With Blood Pressure Reduction in Adults With Type 1 Diabetes.
    Markakis K; Alam T; Jinadev P; Chapman A; Urwin A; Thabit H; Boulton AJM; Rutter MK; Leelarathna L
    J Diabetes Sci Technol; 2019 Jul; 13(4):691-697. PubMed ID: 30636544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Effects of Continuous Subcutaneous Insulin Infusion on Glucose Control and Microvascular Complications in Patients With Type 1 Diabetes.
    Marchand L; Kawasaki-Ogita Y; Place J; Fayolle C; Lauton D; Boulet F; Farret A; Renard E
    J Diabetes Sci Technol; 2017 Sep; 11(5):924-929. PubMed ID: 28303725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus].
    Hasselmann C; Bonnemaison E; Faure N; Mercat I; Bouillo Pépin-Donat M; Magontier N; Chantepie A; Labarthe F
    Arch Pediatr; 2012 Jun; 19(6):593-8. PubMed ID: 22584198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
    Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
    J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of continuous subcutaneous insulin infusion (CSII) therapy in preschool children.
    Levy-Shraga Y; Lerner-Geva L; Modan-Moses D; Graph-Barel C; Mazor-Aronovitch K; Boyko V; Pinhas-Hamiel O
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):225-9. PubMed ID: 23329580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use and Effectiveness of Continuous Subcutaneous Insulin Infusion (CSII) and Multiple Daily Insulin Injection Therapy (MIT) in Children, Adolescents and Young Adults with Type 1 Diabetes Mellitus.
    Schiel R; Burgard D; Perenthaler T; Stein G; Kramer G; Steveling A
    Exp Clin Endocrinol Diabetes; 2016 Feb; 124(2):99-104. PubMed ID: 26895277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low uptake of continuous subcutaneous insulin infusion therapy in people with type 1 diabetes in Ireland: a retrospective cross-sectional study.
    Gajewska KA; Bennett K; Biesma R; Sreenan S
    BMC Endocr Disord; 2020 Jun; 20(1):92. PubMed ID: 32576284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different insulin pump makes under routine care conditions in adults with Type 1 diabetes.
    Leelarathna L; Roberts SA; Hindle A; Markakis K; Alam T; Chapman A; Morris J; Urwin A; Jinadev P; Rutter MK
    Diabet Med; 2017 Oct; 34(10):1372-1379. PubMed ID: 28636773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Effectiveness of Continuous Subcutaneous Insulin Infusion in the Prevention of Hypoglycemia in Adults with Type 1 Diabetes.
    Summers JC; Briganti EM; Fitzgerald ZA; Lambers LNJ; Cohen ND
    Diabetes Technol Ther; 2019 Aug; 21(8):423-429. PubMed ID: 31180239
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment Modality-Dependent Risk of Diabetic Ketoacidosis in Patients with Type 1 Diabetes: Danish Adult Diabetes Database Study.
    Hoshina S; Andersen GS; Jørgensen ME; Ridderstråle M; Vistisen D; Andersen HU
    Diabetes Technol Ther; 2018 Mar; 20(3):229-234. PubMed ID: 29437465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N; Shashaj B
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials and observational studies.
    Rys PM; Ludwig-Slomczynska AH; Cyganek K; Malecki MT
    Eur J Endocrinol; 2018 May; 178(5):545-563. PubMed ID: 29545258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
    Potti LG; Haines ST
    J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes.
    Olsen B; Johannesen J; Fredheim S; Svensson J;
    Pediatr Diabetes; 2015 Jun; 16(4):256-62. PubMed ID: 25082292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
    Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
    BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with continuous subcutaneous insulin infusion is associated with lower arterial stiffness.
    Rosenlund S; Theilade S; Hansen TW; Andersen S; Rossing P
    Acta Diabetol; 2014 Dec; 51(6):955-62. PubMed ID: 25274393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Continuous subcutaneous insulin infusion in children less than 6 years-old: long-term progress].
    Colino E; Martín Frías M; Roldán B; Álvarez MÁ; Yelmo R; Barrio R
    An Pediatr (Barc); 2017 Nov; 87(5):276-283. PubMed ID: 28233713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus.
    Misso ML; Egberts KJ; Page M; O'Connor D; Shaw J
    Cochrane Database Syst Rev; 2010 Jan; (1):CD005103. PubMed ID: 20091571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Continuous subcutaneous insulin infusion].
    Balsa AM; Neves C; Alves M; Pereira M; Carvalho D; Medina JL
    Acta Med Port; 2011 Dec; 24 Suppl 2():147-56. PubMed ID: 22849898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
    Cummins E; Royle P; Snaith A; Greene A; Robertson L; McIntyre L; Waugh N
    Health Technol Assess; 2010 Feb; 14(11):iii-iv, xi-xvi, 1-181. PubMed ID: 20223123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.